Abstract: Amide compounds, amide polymers, compositions including amide compounds and amide polymers may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, amide compounds and amide polymers may include a core derived from an amide polyol and an organic polyacid or ester.

Abstract: Disclosed is a pharmaceutical composition comprising a stable polyallylamine hydrochloride polymer in which between about 4% to about 12% by weight of the polymer is a chloride anion and a pharmaceutically acceptable carrier or diluent.

Abstract: Disclosed is a polymer or physiologically acceptable salt thereof. The polymer comprises a polymerized multifunctional amine monomer. The amine monomer comprises at least two amine groups and at least two acyclic nitrogen atoms that are connected through a —CH2CH2— group, provided that the amine monomer is not ethylenediamine or diethylenetriamine. The disclosed polymers can be used to bind anions in subject in need of such treatment.

Abstract: Compounds, polymers, crosslinked polymers and pharmaceutical compositions comprising the same may be derived from multi-amine monomers and multi-functional monomers having two or more amine reactive groups. Such compounds, polymers, crosslinked polymers and compositions may be used to treat hyperphosphatemia or to remove ions from the gastrointestinal tract of animals, including humans.

Abstract: A communication system provides for establishing a communication environment where multiple media applications can share the same communication channel in a communication session. When establishing a communication session, an application or media application can create a token that can include information regarding resources assigned to or to be used with the communication session. The token may then be used and interpreted by other applications. When communicating during a communication session, the applications and/or components negotiate for access to ports or communication channels assigned to the communication session. Thus, two or more applications may use the same port(s) during the session by obtaining the token and accessing the resources assigned to the token. In this way, fewer ports or channels are used by the multiple applications by sharing resources.

Abstract: A tubing centralizing apparatus has a centralizer body including opposing end portions, a central passage extending through the opposing end portions, and a plurality of apertures extending therethrough between its exterior side surface and the central passage. The apertures are uniformly spaced about a longitudinal axis of the central passage. Bow springs are mounted on the exterior side surface of the centralizer body such that a central portion of each one of the bow springs is bowed away from the centralizer body. The tubing sub is slideably positioned within the central passage of the centralizer body. One of the tubing joint collars is attached to each end portion of the tubing sub. The tubing joint collars and the centralizer body are jointly configured such that the tubing joint collars engage the centralizer body for constraining the tubing sub within the central passage of the centralizer body.

Abstract: Compounds, polymers, crosslinked polymers and pharmaceutical compositions comprising the same may be derived from multi-amine monomers and multi-functional monomers having two or more amine reactive groups. Such compounds, polymers, crosslinked polymers and compositions may be used to treat hyperphosphatemia or to remove ions from the gastrointestinal tract of animals, including humans.

Abstract: An electronic device for impressioning a lock comprises a housing having a key decoder secured to the housing and a connector for connection to electronic circuitry. A key decoder portion extends from the housing for insertion into a keyway. A groove extends along a surface of the key decoder. An insulated conductor is positioned in the groove. An exposed portion serves as a reader of wafers positions in the keyway as the key decoder slides through the keyway. An electrical measuring device is secured to the housing and includes a slidable member including the reader, both of which are connected through a sensor interface included in the housing. When the reader engages and disengages with a wafer, the measuring device transmits electrical signals to the electronic circuitry which mathematically calculates a cut in a key blank for each wafer using stored programs for fitting a key to the lock.

Abstract: This invention relates to crosslinked amine-containing polymers for binding compounds or ions, and more specifically relates to pharmaceutically acceptable compositions for binding compounds or ions that include crosslinked amine-containing polymers. The pharmaceutically acceptable composition includes, for example, crosslinked polyamine particles, or pharmaceutically acceptable salts thereof, having a particle size distribution wherein greater than 10 vol. % of the particles have a particle size greater than 500 ?m.

Abstract: An electronic device for impressioning a lock comprises a housing having a key decoder secured to the housing and a connector for connection to electronic circuitry. A key decoder portion extends from the housing for insertion into a keyway. A groove extends along a surface of the key decoder. An insulated conductor is positioned in the groove. An exposed portion serves as a reader of wafers positions in the keyway as the key decoder slides through the keyway. An electrical measuring device is secured to the housing and includes a slidable member including the reader, both of which are connected through a sensor interface included in the housing.

Abstract: A system permits a user's activity in relation to a physical location to be associated with a virtual community web site and, therefore, with a virtual community created by the web site. Users indicate their presence at, or association with, a physical location by sending messages from their personal communication devices, such as mobile telephones or Internet-connected computers. Users may participate in activities at the locations by sending such messages, accessing location proxy web sites or via virtual communities. An exemplary activity includes a network-connected jukebox. Users may obtain information about music being played on the jukebox. In addition, the jukebox may display information about music being played on other jukeboxes, possibly in other locations.

Abstract: The invention relates to methods for treating hypercholesterolemia and atherosclerosis, and reducing serum cholesterol in a mammal. The methods of the invention comprise administering to a mammal a first amount of a bile acid sequestrant compound which is an unsubstituted polydiallylamine polymer and a second amount of a cholesterol-lowering agent. The first and second amounts together comprise a therapeutically effective amount. The invention further relates to pharmaceutical compositions useful for the treatment of hypercholesterolemia and atherosclerosis, and for reducing serum cholesterol. The pharmaceutical compositions comprise a combination of a first amount of an unsubstituted polydiallylamine polymer compound and a second amount of a cholesterol-lowering agent. The first and second amounts comprise a therapeutically effective amount. The pharmaceutical compositions of the present invention may optionally contain a pharmaceutically acceptable carrier.

Abstract: Disclosed is a polymer or physiologically acceptable salt thereof. The polymer comprises a polymerized multifunctional amine monomer. The amine monomer comprises at least two amine groups and at least two acyclic nitrogen atoms that are connected through a —CH2CH2— group, provided that the amine monomer is not ethylenediamine or diethylenetriamine. The disclosed polymers can be used to bind anions in subject in need of such treatment.

Abstract: Amine compounds, amine polymers, crosslinked amine polymers and pharmaceutical compositions comprising the same may include polyhydroxy-containing cores that may be substituted with amine groups and may be used to treat hyperphosphatemia or to remove ions from the gastrointestinal tract of animals, including humans.

Abstract: Sulfone-containing copolymers and copolymer networks and compositions including sulfone-containing copolymers and copolymer networks may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, sulfone-containing copolymers and copolymer networks may be derived from a multi-amine monomer and a multifunctional sulfonyl-containing monomer comprising two or more amine-reactive groups.

Abstract: Systems and methods of making secure communications in a communications network comprising a user device (2) connectable to the network (12) and comprising encryption/decryption means (8) operative after connection, a recipient device (4) is connectable to the user device via an intermediary device (10) having an intermediary contact number and complimentary encryption/decryption means (8) to the user device encryption/decryption means; in use, when the user device connects to the intermediary device using the intermediary contact number, the intermediary device securely obtains a recipient contact number and enables encrypted connection at least between the user and server (10).

Abstract: Amide compounds, amide polymers and compositions, including amide compounds and amide polymers, may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, the amide polymers may be amido-amine dendrimers that may be formed via a series of iterative reactions.

Abstract: A pharmaceutical composition comprises a pharmaceutically acceptable ferrous iron compound; an amine polymer or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. Alternatively, a pharmaceutical composition comprises a pharmaceutically acceptable ferrous iron compound and pharmaceutically acceptable carrier, wherein the ferrous iron compound is selected from the group consisting of iron(II) acetate, iron(II) citrate, iron(II) ascorbate, iron(II) oxalate, iron(II) oxide, iron(II) carbonate, iron(II) carbonate saccharated, iron(II) formate, iron(II) sulfate, iron(II) chloride, iron(II) acetylacetonate and combinations thereof. A method of treating a subject with hyperphosphatemia comprises administering to the subject an effective amount of a pharmaceutical composition as described above.

Abstract: A pharmaceutical composition for treating hyperphosphatemia can include polymers derived from multi-amine monomers and multifunctional monomers, where the multifunctional monomer includes more than one electrophilic group.

Abstract: Ion binding compounds and compositions may include compounds, polymers and compositions that include amine moieties. Ion binding polymers may be crosslinked amine polymers and may be used to remove ions, such as phosphate ions, from the gastrointestinal tract of animals, such as humans. Such compounds, polymers and compositions may be used therapeutically to treat a variety of medical conditions, such as hyperphosphatemia.